New Science from AHA Scientific Sessions 2022 - CVD Risk Management in Patients with T2D
Diabetes & Heart Disease: The Clinical Connection
Release Date: 02/07/2023
Preventing Strokes in Type 2 Diabetes
Diabetes & Heart Disease: The Clinical Connection
Listen to Walter N. Kernan, MD, Heather Ferris, MD, PhD, and Alejandro A. Rabinstein, MD discuss preventing strokes in type 2 diabetes, risk factors for stroke, treatment and management options for stroke prevention, and the importance of multidisciplinary team care.
info_outline
Heart Failure, Chronic Kidney Disease, and Type 2 Diabetes
Diabetes & Heart Disease: The Clinical Connection
Listen to Katherine R. Tuttle, MD, FASN, FACP, FNKF, Anthony Good, DNP, MBA, FNP-BC, GNP-BC, and Joshua J. Neumiller, PharmD, CDCES, FASCP, FADCES discuss the prevalence of heart failure, chronic kidney disease, type 2 diabetes, and the impact these conditions have on patient outcomes. Management options to mitigate these risks, current guidelines and diagnostic practices will also be discussed.
info_outline
Understanding ASCVD Progression in Patients with Type 2 Diabetes, and Strategies to Assess its Risk
Diabetes & Heart Disease: The Clinical Connection
Listen to Rodica Busui (Pop-Busui), MD, PhD, Neha J. Pagidipati, MD, MPH, and Jennifer B. Green, MD discuss ASCVD (atherosclerotic cardiovascular disease) progression in patients with type 2 diabetes, strategies to assess its risk, and the COORDINATE study.
info_outline
Is Chronic Kidney Disease in Type 2 Diabetes Preventable?
Diabetes & Heart Disease: The Clinical Connection
Listen to Michael J. Blaha, MD, MPH and Richard E. Pratley, MD discuss the link between type 2 diabetes and chronic kidney disease (CKD) as well as taking a multidisciplinary approach to managing people with type 2 diabetes at risk for chronic kidney disease progression.
info_outline
Cultural Considerations in Type 2 Diabetes and Cardiovascular Disease
Diabetes & Heart Disease: The Clinical Connection
Listen to Traci Thompson, MD, MBA, CPE, Latha Palaniappan, MD, MS, and Alka Kanaya, MD discuss racial and ethnic considerations when screening and managing patients with type 2 diabetes (T2D) and cardiovascular disease (CVD), as well as related health care disparities and barriers in managing and treating T2D and CVD.
info_outline
New Science from AHA Scientific Sessions 2022 - CVD Risk Management in Patients with T2D
Diabetes & Heart Disease: The Clinical Connection
This podcast highlights the new science presented at the American Heart Association’s (AHA’s) Scientific Sessions in 2022. Jane Reusch, MD, Nathan Wong, PhD, MPH, and Chiadi Ndumele, MD, PhD, MHS discuss clinical highlights related to CVD risk management in patients with diabetes, including renal disease, and how to incorporate these findings into clinical practice.
info_outline
Life’s Essential 8™
Diabetes & Heart Disease: The Clinical Connection
Help patients with diabetes manage their risk for heart disease and stroke. Donald Lloyd-Jones, MD, ScM, FAHA, FACC and Jane EB Reusch, MD, FAHA discuss the recent release of AHA’s Life’s Essential 8 which was expanded from Life’s Simple 7 to include healthy sleep for optimal cardiovascular health as well as other lifestyle factors included in Life’s Essential 8 and how health care professionals can use this checklist to help patients with diabetes manage their risk for heart disease and stroke.
info_outline
Three Basic Targets
Diabetes & Heart Disease: The Clinical Connection
Diabetes is more than a blood sugar problem. Help your patients with type 2 diabetes understand their risk of cardiovascular disease and the importance of blood pressure, lipid, and glucose control in managing risk. Listen to Nathan Wong, PhD, MPH and Colette Knight, MD discuss ways for patients to know and understand their numbers in LDL cholesterol, triglycerides, blood pressure, A1C, and more.
info_outline
Initiative Update
Diabetes & Heart Disease: The Clinical Connection
Listen to Eduardo Sanchez, MD, MPH, FAHA and Robert A. Gabbay, MD, PhD give an update on the initiative from launch through 2021 including notable insights, key learnings and future outlook as well as empowering patients to be active members of their health care team.
info_outlineThis podcast highlights the new science presented at the American Heart Association’s (AHA’s) Scientific Sessions in 2022. Jane Reusch, MD, Nathan Wong, PhD, MPH, and Chiadi Ndumele, MD, PhD, MHS discuss clinical highlights related to CVD risk management in patients with diabetes, including renal disease, and how to incorporate these findings into clinical practice.